News

Article

Presentation on the Manufacture of Highly Potent Oral Solid-Dosage Forms

At CPhI Worldwide 2018, Tom Wilson, vice president of Contract Manufacturing Operations for Pfizer Global Supply and Pfizer CentreOne Contract Manufacturing, will discuss best practices for meeting manufacturing challenges of compliance as requirements shift.

As drugs in development become more potent, regulatory expectations change, forcing manufacturers to adapt.

Tom Wilson, vice president of Contract Manufacturing Operations for Pfizer Global Supply and Pfizer CentreOne Contract Manufacturing, will discuss best practices for meeting the challenges of compliance as requirements shift using Pfizer’s Newbridge, Ireland, facility as a model.

As vice president of Contract Manufacturing Operations for Pfizer Global Supply (PGS) and Pfizer CentreOne Contract Manufacturing, Wilson serves as manufacturing liaison between the two organizations. In previous roles, he led Pfizer Optionality Program for PGS, as well as the integration team for Hospira Device Operations; oversaw management of Pfizer’s Alliance External Suppliers worldwide; and provided counsel on Pfizer’s global manufacturing strategy. He joined Pfizer in 2010 with the acquisition of Wyeth, where he was vice president of Product Operations.

This insight briefing will take place at CPhI Worldwide in Madrid, Spain, on Wednesday, Oct. 10, 2018, 1:10pm–1:40pm at the ICSE Theatre, Hall 1, stand 1G90.

Source: CPhI

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content